SEARCH

SEARCH BY CITATION

References

  • 1
    Chandran M, Phillips SA, Ciaraldi T, Henry RR. Adiponectin: more than just another fat cell hormone? Diabetes Care 2003;26:24422450.
  • 2
    Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 2005;26:439451.
  • 3
    van Kruijsdijk RC, van der Wall E, Visseren FL. Obesity and cancer: the role of dysfunctional adipose tissue. Cancer Epidemiol Biomarkers Prev 2009;18:25692578.
  • 4
    Antoniades C, Antonopoulos AS, Tousoulis D, Stefanadis C. Adiponectin: from obesity to cardiovascular disease. Obes Rev 2009;10:269279.
  • 5
    Heid IM, Wagner SA, Gohlke H et al. Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1,727 healthy Caucasians. Diabetes 2006;55:375384.
  • 6
    Duncan BB, Schmidt MI, Pankow JS et al. Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 2004;53:24732478.
  • 7
    Menzaghi C, Trischitta V, Doria A. Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease. Diabetes 2007;56:11981209.
  • 8
    Heid IM, Henneman P, Hicks A et al. Clear detection of ADIPOQ locus as the major gene for plasma adiponectin: results of genome-wide association analyses including 4659 European individuals. Atherosclerosis 2010;208:412420.
  • 9
    Centers for Disease Control and Prevention (CDC). Differences in prevalence of obesity among black, white, and Hispanic adults—United States, 2006–2008. MMWR Morb Mortal Wkly Rep 2009;58:740744.
  • 10
    Signorello LB, Hargreaves MK, Steinwandel MD et al. Southern community cohort study: establishing a cohort to investigate health disparities. J Natl Med Assoc 2005;97:972979.
  • 11
    International HapMap Consortium. The International HapMap Project. Nature 2003;426:789796.
  • 12
    Carlson CS, Eberle MA, Rieder MJ et al. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 2004;74:106120.
  • 13
    Tian C, Gregersen PK, Seldin MF. Accounting for ancestry: population substructure and genome-wide association studies. Hum Mol Genet 2008;17:R143R150.
  • 14
    Pritchard JK, Stephens M, Donnelly P. Inference of population structure using multilocus genotype data. Genetics 2000;155:945959.
  • 15
    Lettre G, Lange C, Hirschhorn JN. Genetic model testing and statistical power in population-based association studies of quantitative traits. Genet Epidemiol 2007;31:358362.
  • 16
    Price AL, Patterson NJ, Plenge RM et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006;38:904909.
  • 17
    Ling H, Waterworth DM, Stirnadel HA et al. Genome-wide linkage and association analyses to identify genes influencing adiponectin levels: the GEMS Study. Obesity (Silver Spring) 2009;17:737744.
  • 18
    Richards JB, Waterworth D, O'Rahilly S et al.; GIANT Consortium. A genome-wide association study reveals variants in ARL15 that influence adiponectin levels. PLoS Genet 2009;5:e1000768.
  • 19
    Menzaghi C, Ercolino T, Salvemini L et al. Multigenic control of serum adiponectin levels: evidence for a role of the APM1 gene and a locus on 14q13. Physiol Genomics 2004;19:170174.
  • 20
    Tankó LB, Siddiq A, Lecoeur C et al. ACDC/adiponectin and PPAR-gamma gene polymorphisms: implications for features of obesity. Obes Res 2005;13:21132121.
  • 21
    Vasseur F, Helbecque N, Lobbens S et al. Hypoadiponectinaemia and high risk of type 2 diabetes are associated with adiponectin-encoding (ACDC) gene promoter variants in morbid obesity: evidence for a role of ACDC in diabesity. Diabetologia 2005;48:892899.
  • 22
    Schwarz PE, Towers GW, Fischer S et al. Hypoadiponectinemia is associated with progression toward type 2 diabetes and genetic variation in the ADIPOQ gene promoter. Diabetes Care 2006;29:16451650.
  • 23
    Berthier MT, Houde A, Côté M et al. Impact of adiponectin gene polymorphisms on plasma lipoprotein and adiponectin concentrations of viscerally obese men. J Lipid Res 2005;46:237244.
  • 24
    González-Sánchez JL, Zabena CA, Martínez-Larrad MT et al. An SNP in the adiponectin gene is associated with decreased serum adiponectin levels and risk for impaired glucose tolerance. Obes Res 2005;13:807812.
  • 25
    Mackevics V, Heid IM, Wagner SA et al. The adiponectin gene is associated with adiponectin levels but not with characteristics of the insulin resistance syndrome in healthy Caucasians. Eur J Hum Genet 2006;14:349356.
  • 26
    Salmenniemi U, Zacharova J, Ruotsalainen E et al. Association of adiponectin level and variants in the adiponectin gene with glucose metabolism, energy expenditure, and cytokines in offspring of type 2 diabetic patients. J Clin Endocrinol Metab 2005;90:42164223.
  • 27
    Loos RJ, Ruchat S, Rankinen T et al. Adiponectin and adiponectin receptor gene variants in relation to resting metabolic rate, respiratory quotient, and adiposity-related phenotypes in the Quebec Family Study. Am J Clin Nutr 2007;85:2634.
  • 28
    Jang Y, Chae JS, Koh SJ et al. The influence of the adiponectin gene on adiponectin concentrations and parameters of metabolic syndrome in non-diabetic Korean women. Clin Chim Acta 2008;391:8590.
  • 29
    Vasseur F, Helbecque N, Dina C et al. Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet 2002;11:26072614.
  • 30
    Hivert MF, Manning AK, McAteer JB et al. Common variants in the adiponectin gene (ADIPOQ) associated with plasma adiponectin levels, type 2 diabetes, and diabetes-related quantitative traits: the Framingham Offspring Study. Diabetes 2008;57:33533359.
  • 31
    Kyriakou T, Collins LJ, Spencer-Jones NJ et al. Adiponectin gene ADIPOQ SNP associations with serum adiponectin in two female populations and effects of SNPs on promoter activity. J Hum Genet 2008;53:718727.
  • 32
    Guo X, Saad MF, Langefeld CD et al. Genome-wide linkage of plasma adiponectin reveals a major locus on chromosome 3q distinct from the adiponectin structural gene: the IRAS family study. Diabetes 2006;55:17231730.
  • 33
    Ukkola O, Santaniemi M, Rankinen T et al. Adiponectin polymorphisms, adiposity and insulin metabolism: HERITAGE family study and Oulu diabetic study. Ann Med 2005;37:141150.
  • 34
    Wassel CL, Pankow JS, Jacobs DR Jr., Steffes MW, Li N, Schreiner PJ. Variants in the adiponectin gene and serum adiponectin: the Coronary Artery Development in Young Adults (CARDIA) study. Obesity (Silver Spring), 2010;18:23332338.
  • 35
    Stumvoll M, Tschritter O, Fritsche A, Staiger H, Renn W, Weisser M, Machicao F, and Haring H. Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes. Diabetes 2002;51:3741.
  • 36
    Yang WS, Tsou PL, Lee WJ et al. Allele-specific differential expression of a common adiponectin gene polymorphism related to obesity. J Mol Med 2003;81:428434.
  • 37
    Sutton BS, Weinert S, Langefeld CD et al. Genetic analysis of adiponectin and obesity in Hispanic families: the IRAS Family Study. Hum Genet 2005;117:107118.
  • 38
    Warodomwichit D, Shen J, Arnett DK et al. ADIPOQ polymorphisms, monounsaturated fatty acids, and obesity risk: the GOLDN study. Obesity (Silver Spring) 2009;17:510517.
  • 39
    Lee SA, Kallianpur A, Xiang YB et al. Intra-individual variation of plasma adipokine levels and utility of single measurement of these biomarkers in population-based studies. Cancer Epidemiol Biomarkers Prev 2007;16:24642470.
  • 40
    Gorber SC, Tremblay M, Moher D, Gorber B. A comparison of direct vs. self-report measures for assessing height, weight and body mass index: a systematic review. Obes Rev 2007;8:307326.
  • 41
    Stanforth PR, Jackson AS, Green JS et al. Generalized abdominal visceral fat prediction models for black and white adults aged 17–65 y: the HERITAGE Family Study. Int J Obes Relat Metab Disord 2004;28:925932.
  • 42
    Westfall PH, Tobias RD, Rom D, Wolfinger RD, Hochberg Y. Multiple Comparisons and Multiple Tests Using the SAS System. SAS Institute: Cary, NC, 1999.